Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma

Emerging data support the rationale of combined therapies in advanced melanoma. Specifically, the combined use of drugs with different mechanisms of action can reduce the probability of selecting resistant clones. To identify agents active against melanoma cells, we screened a library of 349 anti‐ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedini, Francesca, De Luca, Gabriele, Felicetti, Federica, Puglisi, Rossella, Boe, Alessandra, Arasi, Maria Beatrice, Fratini, Federica, Mattia, Gianfranco, Spada, Massimo, Caporali, Simona, Biffoni, Mauro, Giuliani, Alessandro, Carè, Alessandra, Felli, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717748/
https://www.ncbi.nlm.nih.gov/pubmed/31115969
http://dx.doi.org/10.1002/1878-0261.12506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717748/
https://www.ncbi.nlm.nih.gov/pubmed/31115969
http://dx.doi.org/10.1002/1878-0261.12506

Ejemplares similares